Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Total Liabilities: 2018-2024

Historic Total Liabilities for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to $293.1 million.

  • Revolution Medicines' Total Liabilities rose 233.01% to $655.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $655.0 million, marking a year-over-year increase of 233.01%. This contributed to the annual value of $293.1 million for FY2024, which is 24.45% up from last year.
  • Per Revolution Medicines' latest filing, its Total Liabilities stood at $293.1 million for FY2024, which was up 24.45% from $235.5 million recorded in FY2023.
  • Revolution Medicines' Total Liabilities' 5-year high stood at $293.1 million during FY2024, with a 5-year trough of $92.7 million in FY2020.
  • Its 3-year average for Total Liabilities is $218.4 million, with a median of $235.5 million in 2023.
  • Its Total Liabilities has fluctuated over the past 5 years, first fell by 6.41% in 2022, then spiked by 85.82% in 2023.
  • Over the past 5 years, Revolution Medicines' Total Liabilities (Yearly) stood at $92.7 million in 2020, then spiked by 46.04% to $135.4 million in 2021, then declined by 6.41% to $126.7 million in 2022, then skyrocketed by 85.82% to $235.5 million in 2023, then increased by 24.45% to $293.1 million in 2024.